Sanjay H. Chotirmall

Nanyang Technological University — Singapore

Medicine · Health Sciences

52h-index9.2kcitations349works7.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(138), Neonatal Respiratory Health Research(67), Chronic Obstructive Pulmonary Disease (COPD) Research(57), Pediatric health and respiratory diseases(48), Tracheal and airway disorders(46)

Publications349 total

Gut–lung microbial dynamics with lumacaftor/ivacaftor in children with cystic fibrosis: a prospective multicenter study
Pediatric Research·2026
Lower Airway Dysbiosis in NTM+ Bronchiectasis is Associated with NET-Predominant Severe Phenotypes
American Journal of Respiratory and Critical Care Medicine·2026
The Airway Microbiome in Chronic Obstructive Pulmonary Disease (COPD): A Guide for Clinicians
British Journal of Hospital Medicine·2026Open Access
Multi-omics to study chronic respiratory diseases and viral infections.
PubMed·2026Open Access
Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis
The Lancet Respiratory Medicine·2026
Reply: Methodological clarifications of AI-powered research trend analytics in bronchiectasis
European Respiratory Journal·2026
Fungal-Associated Endotypes as a Treatable Trait in Bronchiectasis
Pulmonary Therapy·2025Open Access
Stress-induced toxic genomic R-loops support biofilm extracellular matrix formation
Nature Communications·2025Open Access
MSR173 Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data
Value in Health·2025
Allergic bronchopulmonary aspergillosis and Aspergillus-related airway diseases in bronchiectasis: a narrative review
Journal of Thoracic Disease·2025Open Access
Aspergillus fumigatus Sensitization Is Associated With High-Risk Bronchiectasis
CHEST Journal·2025
Integrated multi-omics profiling for risk stratification in Asians with COPD
Respiratory Research·2025Open Access
Economic burden of asthma multimorbidity in Singapore: Shadow costs of steroid use
World Allergy Organization Journal·2025Open Access
S58 Viral infection perturbs the respiratory mycobiome in COPD
2025
Multidrug-resistant <i>Haemophilus influenzae</i> cluster of severe asthma from sputum bacteriome-resistome
ERJ Open Research·2025Open Access
OPENing the door for patient and public involvement in medical research in Singapore
Research Involvement and Engagement·2025Open Access
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network
ERJ Open Research·2025Open Access
104 A phase III study (AIRTIVITY) to assess the efficacy, safety and tolerability of the DPP1 (CatC) inhibitor BI 1291583 in adults and adolescents with bronchiectasis of various etiologies
Journal of Cystic Fibrosis·2025
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis
European Respiratory Journal·2025· 30 cited
Subgroup analysis: AIRLEAF® Phase II study of a cathepsin C (CatC, or DPP1) inhibitor, BI 1291583, in adults with non–cystic fibrosis bronchiectasis
2025
page 1 of 18Next →

Frequent Co-authors

Noel G. McElvaney(17), Micheál Mac Aogáin(15), James D. Chalmers(13), Pei Yee Tiew(10), Mariko Siyue Koh(10), John Abisheganaden(9), Catherine M. Greene(9), Tavleen Kaur Jaggi(7), Albert Yick Hou Lim(7), Shane O’Neill(6), Holly R. Keir(6), Teck Boon Low(6), Thun How Ong(6), Tidi Hassan(6), Fook Tim Chew(6), Nur A’tikah Binte Mohamed Ali(5), Augustine Tee(5), Sze Lei Pang(5), Philip M. Hansbro(4), Alison Dicker(4)